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Abstract
Protein modification with poly-ubiquitin chains is a crucial process
involved in a myriad of cellular pathways. Chain synthesis requires
two steps: substrate modification with ubiquitin (priming)
followed by repetitive ubiquitin-to-ubiquitin attachment (elonga-
tion). RING-type E3 ligases catalyze both reactions in collaboration
with specific priming and elongating E2 enzymes. We provide
kinetic insight into poly-ubiquitylation during protein quality
control by showing that priming is the rate-determining step in
protein degradation as directed by the yeast ERAD RING E3 ligases,
Hrd1 and Doa10. Doa10 cooperates with the dedicated priming E2,
Ubc6, while both E3s use Ubc7 for elongation. Here, we provide
direct evidence that Hrd1 uses Ubc7 also for priming. We found
that Ubc6 has an unusually high basal activity that does not
require strong stimulation from an E3. Doa10 exploits this property
to pair with Ubc6 over Ubc7 during priming. Our work not only
illuminates the mechanisms of specific E2/E3 interplay in ERAD,
but also offers a basis to understand how RING E3s may have prop-
erties that are tailored to pair with their preferred E2s.
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Introduction
The post-translational modifier ubiquitin (Ub) controls virtually
every process in eukaryotic cells. Protein modification with Ub is
carried out by three sequentially acting enzymes. The E1 enzyme
activates the Ub C-terminus for transfer to the active site of an E2
enzyme to form an E2~Ub thioester conjugate (in this text, “~” signi-
fies the thioester linkage). E3 ligases are generally attributed with
two functions: They bring an E2~Ub conjugate and a suitable
substrate into proximity (“recruitment”), and they catalyze the trans-
fer of Ub from the E2 to the substrate thus ensuring spatiotemporal
control of the process (“stimulation”). All eukaryotic organisms from
yeast to human have a hierarchy of E1/E2/E3 enzymes, with 1–2
human E1s, up to 36 E2s, and hundreds of E3s. The hierarchy
dictates that a given E2 must work with numerous E3s, but it is also
true that numerous E2s can work with a given E3. For the largest
family of E3s, the RING E3s, the identity of the collaborating E2
defines the product of the reaction (i.e., mono- or poly-ubiquityla-
tion) and, therefore, the biological outcome (Christensen et al,
2007). How an E3 pairs with a specific E2—from the set of enzymes
it can physically interact with—to determine a distinct functional
outcome remains an open question.
The ability to stimulate E2 activity is rooted in the way RING E3
ligases function. They bind an E2~Ub conjugate and stimulate Ub
transfer to a substrate without participating directly in the reaction. In
solution, Ub conjugated to an E2 is highly flexible, creating a dynamic
conformational equilibrium that is associated with low transfer activ-
ity (Fig 1A; Pruneda et al, 2011). RING E3s work allosterically by
restricting the flexible Ub toward so-called closed conformations that
involve non-covalent interactions between a hydrophobic surface
patch on Ub and a surface proximal to the E2 active site (Reverter &
Lima, 2005; Saha et al, 2011; Wickliffe et al, 2011; Dou et al, 2012;
Plechanovová et al, 2012; Pruneda et al, 2012; Brown et al, 2014;
Kelly et al, 2014; Branigan et al, 2020). In general, RING E3s achieve
this shift in E2~Ub conformational equilibria through a conserved
residue, the allosteric linchpin, that engages both the Ub and the E2 to
restrict their relative orientations. A shift toward closed conformations
is associated with a dramatic increase in Ub transfer activity from an
E2 (Pruneda et al, 2012; Branigan et al, 2020). Structural data reveal
that a RING linchpin engages Ub and the E2 through hydrogen
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bonding (Fig 1B; Dou et al, 2012; Plechanovová et al, 2012; Pruneda
et al, 2012; Branigan et al, 2015). In a survey of yeast and human
RING-type E3s, arginine, with its multiple hydrogen bond donor
groups, is most commonly found at the linchpin position (Figs 1C and
EV1 for yeast and human, respectively). Surprising, at least half of all
human and yeast RINGs feature a residue other than arginine at the
linchpin position. Some have been reported as functional, but less effi-
cient linchpins than arginine (Yin et al, 2009; Pruneda et al, 2012;
Scott et al, 2014; Stewart et al, 2017); some are residues that can
potentially act as a hydrogen bond donor, but have not been experi-
mentally verified as functional linchpins; some are residues that lack
hydrogen bond potential altogether. Prominent examples include
yeast RING E3s Rad16 (histidine) and Rad18 (leucine), both involved
in DNA damage pathways, and Rbx1 (asparagine), the common RING
module of the large family of cullin-RING ligases (CRLs). How these
RINGs stimulate the ubiquitylation activity of their paired E2s is
largely unknown.
The best-understood types of protein ubiquitylation involve the
formation of poly-Ub chains of specific linkages (e.g., Ub K48- or
K11-linked chains serve as signals for proteasomal degradation)
(Komander & Rape, 2012; Metzger et al, 2013b). For RING-type E3s,
substrate modification with a poly-Ub chain involves two types of
Ub transfer reactions: (i) a “priming” step in which a single Ub is
transferred to a protein substrate and (ii) “elongation” reactions in
which Ub is attached to the substrate-modified Ub to generate a
poly-Ub chain (reviewed in Stewart et al, 2016; Deol et al, 2019).
The priming step is biochemically diverse due to the varied nature of
potential substrates and Ub attachment sites, whereas chain elonga-
tion entails highly specific and repetitive reactions. The different
biochemical requirements of priming and elongation have led to the
recognition of dedicated E2s for each step. Dedicated chain-elon-
gating E2s that specialize in the synthesis of specific Ub linkages
such as K11-, K48-, and K63-linked chains are well known. However,
the identities and mechanisms of specific mono-ubiquitylating prim-
ing E2s and of E2s that appear to carry out both functions are less
well understood. For example, members of the UbcH5 (UBE2D)
family are highly promiscuous in vitro and potentially function in
both priming and elongation capacities. It is likely that their
functional action, i.e., priming or elongation, is dictated by the
particular E3 with which such E2s cooperate in a given case
(summed up by Stewart et al, 2016), but how such a selection is
achieved is not known.
Examples of RING E3s that are confirmed to collaborate with
separate priming and elongation E2s to catalyze attachment of poly-
Ub chains to substrates continue to be reported (Rodrigo-Brenni &
Morgan, 2007; Saha & Deshaies, 2008; Kleiger et al, 2009; Parker &
Ulrich, 2009; Pierce et al, 2009; Williamson et al, 2009; Wu et al,
2010a; Kelly et al, 2014; Scott et al, 2014, 2016; Dove et al, 2016;
Weber et al, 2016; Hill et al, 2019). Still, our understanding of how
E3 ligases control the interplay of E2 enzymes during the two steps
of poly-ubiquitylation is rather limited. To understand how RING
E3s utilize E2s for priming and elongation reactions, we focused on
a well-defined molecular poly-ubiquitylation system. ER-associated
protein degradation (ERAD) is a highly conserved protein quality
control pathway that targets misfolded ER-resident proteins and
marks them for proteasomal degradation (Christianson & Ye, 2014).
Yeast ERAD relies on two RING E3 ligases, Hrd1 and Doa10, and
two E2 enzymes, Ubc6 and Ubc7, to modify substrates with
K48-linked Ub chains (Fig 1D). Ubc6 harbors a C-terminal trans-
membrane domain and is thought to function primarily as a mono-
ubiquitylating priming E2 (Weber et al, 2016). Ubc7 is recruited to
the membrane by the accessory protein Cue1; binding to the Ubc7-
binding region (U7BR) of Cue1 renders Ubc7 competent for Ub
transfer, while the Cue1 domain of the protein serves to align a
growing poly-Ub chain for K48-specific elongation by Ubc7 (Kostova
et al, 2009; Bagola et al, 2013; Metzger et al, 2013a; von Delbrück
et al, 2016). The E3 Doa10 employs Ubc6 and Ubc7 for priming and
elongation, respectively (Weber et al, 2016), while Hrd1 relies
predominantly on Ubc7 (Bays et al, 2001) (Fig 1E). Hrd1-targeted
ubiquitylation is largely unaffected by the absence of Ubc6, implying
that Ubc7 can carry out both priming and elongation with Hrd1.
Nevertheless, no direct evidence for Ubc7’s priming activity has
been reported to date. Notably, Doa10 features a potentially subopti-
mal histidine as its linchpin, while Hrd1 harbors a canonical argi-
nine (Fig 1F). This feature implies different requirements for E3-
mediated E2 stimulation in the two RING E3s, but this notion has
not been directly addressed experimentally.
Our comparisons of the two non-redundant ERAD E3 ligases and
their interacting E2 enzymes lead to several key observations and
conclusions. First, we present direct in vitro evidence that chain-
elongating Ubc7 can work as a priming E2. Second, E3-mediated E2
stimulation contributes to in vivo substrate degradation rates in the
priming step, but is dispensable in the chain elongation step. Third,
Hrd1 and Doa10 exploit different modes of E2 stimulation that are
tailored to the properties of their preferred priming E2. Hrd1 has a
high affinity for Ubc7 and relies on its canonical allosteric linchpin
to stimulate the E2 in the priming reaction. Ubc6 has high basal
activity and does not absolutely rely on stimulation by a functional
linchpin for RING-mediated ubiquitylation. This enables Doa10 with
its non-canonical linchpin residue to use Ubc6 and not Ubc7 for
priming, while not affecting the E3’s use of Ubc7 for chain elonga-
tion to a degree that impinges on protein degradation rates. Alto-
gether, this study provides insight into how E3s functionally pair
with their potential E2s to enable specific functional outcomes.
Results
Hrd1 selects Ubc7 through high binding affinity
To understand the E2 preferences of Hrd1 and Doa10, we character-
ized the catalytically relevant combinations of each E3 ligase with
Ub conjugates of either E2. Isothermal titration calorimetry (ITC)
was performed using the E3 RING domains, a C-terminally trun-
cated version of Ubc6, and Ubc7 in complex with the U7BR of Cue1,
which renders the E2 competent for Ub transfer (Bagola et al,
2013). As the native Ubc6~Ub thioester is susceptible to hydrolysis
(see also later Fig 5C), we engineered stable mimics of E2~Ub thio-
ester conjugates by generating a covalent disulfide linkage between
a Ub(G76C) mutant and the E2 active site cysteine [(Lorenz et al,
2016); “-SS-” signifies the disulfide linkage for these conjugates].
The Hrd1 RING binds the U7BR/Ubc7-SS-Ub conjugate more
than one order of magnitude stronger than it binds the Ubc6-SS-Ub
conjugate, with a KD in the low lM range (Fig 2A). This implies that
Hrd1 selects between Ubc6 and Ubc7 on the basis of E2~Ub/E3
affinity, consistent with the reported Ubc6 independence of Hrd1
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Figure 1. Ubiquitylating enzymes in yeast ERAD and mechanism of RING-mediated E2 stimulation.
A Current model of RING E3-mediated E2 activation.
B RING linchpin-mediated interactions in an E2~Ub/RING complex. Crystal structure of UbcH5a-Ub/RNF4 (PDB: 4AP4) highlighting the hydrogen bond interactions
involving the RING linchpin arginine to side chain and backbone atoms on both the E2 and Ub.
C Histogram of amino acid frequencies at the linchpin position of all 42 yeast RING domains. The linchpin position was defined as the residue at the n + 1 position
after the final Zn2+ ligand coordinating residues. “–” refers to the atypical RING of Pib1, which lacks the loop containing the linchpin. The SP-RING domains of the
two yeast SUMO E3 ligases Siz1 and Siz2 as well as the RING1 domains of the two yeast RBR E3 ligases Hel1 and Itt1 were excluded from this analysis.
D Summary of the relevant properties of E2 enzymes and E3 ligases of the yeast ERAD system.
E Cartoon showing ERAD E2 pairings for both E3 ligases during priming and elongation (see text for details).
F Sequence alignment of Hrd1 and Doa10 for the final Zn2+-binding loops (C-X-X-C) showing the linchpin position.
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substrate degradation (Bays et al, 2001). In contrast, the Doa10
RING binds each E2 conjugate with similar weak affinity, with KDs
in the high lM range, consistent with this E3 cooperating with both
E2s. We note that the dissociation constants measured for the
soluble versions of the RING domains and E2 conjugates reflect the
intrinsic affinity for these functional protein–protein interactions
and, therefore, the probability of an E3 engaging a particular E2~Ub.
Tethering of the relevant components in the ER membrane (see
Fig 1E) may overcome the relatively low intrinsic affinity by provid-
ing high local concentrations of an E3 and its E2~Ub conjugates.
Hrd1 is presumed to collaborate with Ubc7 for both priming
and chain elongation steps, but direct evidence of substrate prim-
ing by Ubc7 has not been reported. We implemented an in vitro
substrate ubiquitylation assay in which a sequence derived from
bovine RNase A (“S-peptide”) is genetically fused to an E3 (e.g.,
“S-Hrd1”) to serve as a high-affinity substrate recruiter for an
RNase A variant that lacks its S-peptide sequence (referred to here
as “RNase”; Bays et al, 2001). The Ub(K48R) mutant was used in
reactions containing Ubc7 to limit reactions to the priming step by
preventing K48-linked poly-Ub chain formation. Reactions that
contain a functional E2/E3 pair will generate a product that corre-
sponds to RNase modified with Ub. The pairing of Ubc7 and S-
Hrd1 yields a robust RNase-Ub band and a fainter RNase-Ub2 band,
which likely reflects double mono-ubiquitylated RNase (Fig 2B). In
the absence of S-Hrd1, Ubc7-mediated ubiquitylation is negligible.
Importantly, this result provides direct evidence that the efficient
chain-elongating E2 Ubc7 is able to prime a substrate. The pairing
of Ubc6 and S-Hrd1 also generated modified RNase, albeit to a
lesser extent, and this reaction does not depend entirely on the
presence of S-Hrd1. Importantly, the stimulatory effect of S-Hrd1,
i.e., the difference of RNase modification in the presence of the E3
compared to its absence, is much greater in the case of Ubc7 than
Ubc6. Altogether, the results indicate that Ubc6/S-Hrd1 can, in
principle, form a functional E2/E3 pair for priming, but is much
less efficient than the Ubc7/S-Hrd1 pair.
Although the in vitro ubiquitylation assay provided insights into
the capability of Ubc6 and Ubc7 to prime a substrate, RNase is an
artificial substrate that interacts with the E3 ligase in a non-native
way. To obtain a quantitative measure of E2 activity and the poten-
tial of E3s to stimulate it without confounding contributions from a
substrate, we monitored the kinetics of Ub transfer from preformed
E2~Ub conjugates to a small nucleophile (see Fig EV2A; Pickart &
Rose, 1985; Wenzel et al, 2011). Nucleophile is present at huge
molar excess thus circumventing the need for a specific substrate
interaction. Ub discharge from Ubc6~Ub and U7BR/Ubc7~Ub was
followed as a function of time (Fig 2C), and rates were extracted
(Fig 2D), providing a metric for substrate-independent E2 discharge
activity. While U7BR/Ubc7~Ub undergoes aminolysis like most E2s,
Ubc6 has been reported to be hydroxy-reactive (Wang et al, 2009;
Weber et al, 2016). We therefore used ethanolamine as the nucle-
ophile, as it provides both an amino and a hydroxy group. While this
experimental design allows for uniform reaction conditions, a direct
comparison of the E2s’ discharge rates is inadvisable due to the
inherent reactivity profile differences. Also, the discharge rates
reported here are not directly transferrable to ubiquitylation of
substrate in vivo. Despite these caveats, the assays allow assessment
of the stimulatory effect of an E3 for a given E2, which we report as
the ratio of the discharge rates with and without E3 (Fig 2E). U7BR/
Ubc7~Ub discharges very slowly in the absence of an E3 and Hrd1
greatly accelerates the process. In contrast, Ubc6~Ub discharges
quite rapidly on its own and is only mildly stimulated by Hrd1.
Quantitatively, Hrd1 is roughly an order of magnitude more potent
at stimulating discharge from U7BR/Ubc7 than from Ubc6. These
results are consistent with the observations made in the in vitro
substrate ubiquitylation assays and in line with the difference in
binding affinity. They suggest that the difference observed in the
in vitro ubiquitylation assay (see Fig 2B) is due to Hrd1’s more effec-
tive stimulation of Ubc7. Altogether, the binding and functional
assays indicate that the known functional in vivo preference of Hrd1
for Ubc7 over Ubc6 for priming is dictated mainly by binding
affinity.
RING linchpin plays a key role in Ubc7 stimulation
Having established that Ubc7 can carry out priming with Hrd1, we
wondered why it reportedly does not do so with Doa10, especially
as the competing E2 for priming, Ubc6, binds with comparably
low affinity to Doa10 (see Fig 2A). Hrd1 and Doa10 differ in their
linchpin residues (Arg and His, respectively; see Fig 1F), suggest-
ing the answer might lie in how the two E3s stimulate Ubc7. To
investigate the contribution of linchpins in the stimulation of
Ubc7, we generated Hrd1 and Doa10 RING variants that harbor
one of four amino acids at their linchpin positions (arginine—
potent hydrogen bond donor and linchpin of Hrd1; histidine—
potential hydrogen bond donor and linchpin of Doa10; alanine—
no hydrogen bond potential; or glutamate—hydrogen bond accep-
tor and charge reversal of arginine).
A strong dependence on linchpin identity was observed in Ub
discharge assays for U7BR/Ubc7 acting with either E3 ligase
(Fig 3A): For both, arginine is most effective, histidine and alanine
are much less effective, and glutamate provides only minor stimula-
tion of U7BR/Ubc7 activity over a “no E3” control. Wild-type Hrd1
(400R) elicits the highest Ub discharge rates from U7BR/Ubc7 with
rates achieved by wild-type Doa10(94H) being roughly three times
lower. Notably, Doa10 with an arginine linchpin (94R) is as effective
as wild-type Hrd1. These observations imply that Hrd1-mediated
Ubc7 stimulation is driven by the identity of the linchpin.
The mono-Ub to di-Ub step is the slowest of Ub chain elongation,
but not rate-determining for protein degradation
Doa10’s suboptimal histidine linchpin and Ubc7’s strong linchpin
dependence offer a rationale for why this E3 does not rely on Ubc7
for priming. How this affects Doa10’s preferred use of Ubc6 for
priming will be discussed later. However, Doa10 does engage Ubc7
for chain elongation, begging the question how this is carried out.
We implemented an in vitro assay in which one Ubc7-dependent
elongation step can be monitored at a time (Fig EV3A; von
Delbrück et al, 2016). The first three reactions of chain elongation
were recapitulated by adding Alexa 488-labeled Ub to mono-Ub, di-
Ub, or tri-Ub to generate di-Ub, tri-Ub, or tetra-Ub, respectively.
Reactions were carried out in the absence or presence of Hrd1 or
Doa10 or their linchpin variants, respectively, as well as a variant of
Cue1 that contains both the U7BR and the Cue1 domain. Reaction
rates for each step were derived from quantification of the time
courses (Fig 3B).
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KD (M) U7BR/Ubc7-SS-Ub Ubc6-SS-Ub
Hrd1 (1 ± 0.2) 10-5 (5 ± 3) 10-4
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Similar to Ubc7 discharge assays, the rates of chain elongation
reactions showed a clear dependence on the linchpin identity for
both E3 ligases. As before, the E3 variant with an arginine linchpin
yielded the highest reaction rates, followed by histidine, alanine,
and glutamate; the latter again gave rates close to the “no E3”
control. However, unlike in discharge assays, both wild-type E3s
provide very similar stimulation of Ubc7-mediated elongation in
each reaction step despite the difference in their linchpins (compare
rates with black frames in each step). Thus, the difference in
allosteric Ubc7 stimulation afforded by each E3 does not impact
elongation reactions where the substrate is Ub at the end of a
growing chain.
A comparison of the individual reaction steps revealed that the
first reaction, i.e., mono-Ub to di-Ub, is the slowest with the next
two reactions (di-Ub to tri-Ub and tri-Ub to tetra-Ub) showing
generally comparable and higher rates (see Fig EV3B and C). The
Ubc7 co-factor, Cue1, aligns the end of a growing Ub chain for
modification by binding to the penultimate Ub moiety (von
Delbrück et al, 2016). To parse out the contributions of Cue1 and
the RING linchpin in Ubc7-mediated Ub chain formation, reactions
were carried out with the Cue1(RGA) variant that carries a muta-
tion in its Cue1 domain and thus renders it Ub binding-deficient
and unable to align the growing Ub chain (Bagola et al, 2013).
Similar to previous studies, the Cue1(RGA) mutant shows a large
decrease in rates of reactions using chains of at least di-Ub as
substrate (see di-Ub to tri-Ub and tri-Ub to tetra-Ub in Fig EV3B
and C). In contrast, the Cue1 mutant has no effect on the reactions
that generate di-Ub (see mono-Ub to di-Ub in Fig 3B; von
Delbrück et al, 2016). Notably, in reactions carried out by each
wild-type E3, the Cue1(RGA) mutation consistently reduces rates
to the level of the mono-Ub to di-Ub reaction (highlighted as
“minimal wt rates” in Fig 3B). The results demonstrate that, for
elongation reactions beyond di-Ub, a defect caused by a RING
linchpin mutation in the presence of wild-type Cue1 is smaller or
equal to that of Cue1(RGA) in the presence of wild-type RINGs (in
Fig 3B, compare rates of linchpin variants in di-Ub to tri-Ub reac-
tions with rates of wild-type E3 in Cue1(RGA) background). The
data also reveal that the first reaction of the elongation process is
its kinetic bottleneck.
How are these behaviors reflected in vivo? We were unable to
follow Ub chain formation on ERAD substrates in vivo in a
sufficiently quantitative manner, so we focused on its ultimate
biological outcome, i.e., ERAD substrate degradation. Of course,
substrate ubiquitylation (priming and chain formation) entails only
two steps of many in this process (Fig 3C), but if one or both are
rate-determining, changes in them are predicted to affect the
observed rate of degradation. Pulse-chase and CHX decay assays
were performed in yeast to follow ERAD-mediated protein degrada-
tion of vetted model substrates for each E3 (PrA*-3xHA and Hmg2-
6xMyc for Hrd1; Deg1-eGFP2 and FLAG-Sbh2 for Doa10—see
Figs 3D, and EV4E and EV5E). Relative to strains expressing wild-
type Cue1 and Hrd1 or Doa10, degradation of respective model
substrates is markedly slower in strains lacking the respective E3 or
Cue1. Given the well-documented integral role of the two E3s and of
Cue1 in degradation of these substrates, the deletion strains report
the stability of these substrates in the absence of ERAD-mediated
degradation. In particular, the Hrd1 model substrate Hmg2-6xMyc
(Fig EV4E) and the Doa10 model substrate Deg1-eGFP2 (Fig 3D—
right panel) are not completely stabilized in the Dcue1, Dhrd1, and
Ddoa10 strains, respectively, indicating that these substrates can be
degraded through other pathways.
Remarkably, in the presence of the relevant wild-type E3,
strains that express the Cue1(RGA) mutant show similar model
substrate degradation kinetics to those expressing wild-type Cue1
(Figs 3D and EV4E). Only in the case of the Doa10 model
substrate FLAG-Sbh2 does the Cue1(RGA) mutation have a nega-
tive effect on protein degradation kinetics (Fig EV5E). This effect
is, however, only modest when compared to those in the Ddoa10
and Dcue1 strains, and by the end of the assay, protein levels in
the Cue1(RGA)-expressing strain were similar to those in the
strain expressing the wild-type protein. The simplest explanation
for this overall lack of an effect of the Cue1(RGA) mutant is that
chain elongation is not rate-determining for ERAD protein degra-
dation (see Fig 3C). Furthermore, we can conclude that the first
reaction of chain elongation (mono-Ub to di-Ub) is not rate-
determining for protein degradation in vivo at either E3 ligase
because this step was the slowest in vitro and the Cue1(RGA)
mutation slowed down all elongation steps to the rate of the first
step. If the first step contributed to the experimentally observed
rate of degradation, one would expect that additional reactions
occurring at similar speeds (rather than much faster) would
contribute to the overall rate. As this is not what we observed,
◀ Figure 2. Hrd1 selects Ubc7 through high binding affinity.A Dissociation constants for ERAD E2-SS-Ub/E3 pairs. KD values were determined by ITC titration of Hrd1 or Doa10 to Ubc6-SS-Ub and U7BR/Ubc7-SS-Ub, respectively.
Due to the weak binding, errors are high, so the constants are reported to a single significant figure.
B In vitro substrate ubiquitylation assay for Hrd1 with Ubc7 (left) and Ubc6 (right). Ubc7 reactions contained equimolar amounts of Cue1 and were performed with
Ub(K48R). Top: representative immunoblot using a poly-clonal a-RNase A antibody; “no E3” reactions do not contain S-Hrd1, “no ATP” reactions do not contain ATP,
but S-Hrd1. The RNase-Ub2 band co-migrates with a non-specific band (#) common to all samples. Bottom: Quantification of RNase-Ub signals is shown. Values are
reported as means  standard deviation (n = 3). Significances for pairwise comparisons were determined by one-way ANOVA test; *P < 0.05. For clarity, only
significances related to the “no E3” control of a given E2 are shown.
C In vitro Ub nucleophile discharge assays for Hrd1 with U7BR/Ubc7 (top—yellow) and Ubc6 (bottom—green) with ethanolamine as nucleophile. Representative
Coomassie gels are shown.
D Quantification of Ub nucleophile discharge assays for Hrd1 with U7BR/Ubc7 (left) and Ubc6 (right). Plots of E2~Ub discharge (dots) as a function of time with first-
order reaction models fitted to the discharge data (lines) are shown. Values for each time point are reported as means  standard deviation (n = 3). Insets show
reaction rates derived from these fits. Significances were determined by Student’s t-test; *P < 0.05.
E Stimulation of U7BR/Ubc7 and Ubc6 discharge activities by Hrd1. E2 stimulation is reported as the ratio of rates derived from RING-catalyzed reactions and “no E3”
controls in D. Values are reported as means  standard deviation (n = 3). Significance was determined by Student’s t-test; *P < 0.05.
Source data are available online for this figure.
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we conclude that none of the steps of chain elongation are rate-
determining for substrate degradation as observed in our assays.
This also suggests that the rates observed in vitro for the first step
(“minimal wt rates”) are a lower limit above which effective
protein degradation at both E3s under the conditions assayed
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Linchpin-mediated Ubc7 stimulation during chain elongation is
not crucial for ERAD substrate degradation
The revelation that Ub chain elongation is not rate-determining for
substrate degradation implies two possibilities: (i) either the E3-
dependent priming step is rate-determining or (ii) a process other
than substrate poly-ubiquitylation and independent of an E3 is (see
Fig 3C). To distinguish the two possibilities, linchpin mutants of
Hrd1 and Doa10 were introduced into yeast. As Ubc7 stimulation
depends on the linchpin (see Fig 3A), linchpin variants might allow
us to uncouple the recruitment function of each E3 ligase from their
E2 stimulation function. In pulse-chase experiments tracking Hrd1
model substrate degradation, we observed a dependence of
substrate degradation on the identity of the Hrd1 linchpin (Figs 4A
—left panel and EV4A) with similar trends to those in vitro:
Substrate degradation occurs most rapidly in the strain expressing
wild-type Hrd1 with its arginine linchpin, followed by histidine and
alanine linchpin mutants. Expression of Hrd1 with a glutamate
linchpin results in degradation impaired to a degree comparable to a
strain that lacks Hrd1 altogether.
The fact that substrate degradation rates are detectably altered by
introduction of Hrd1 linchpin mutations suggests that there is a
Hrd1-dependent step that is rate-determining. In in vitro chain elon-
gation assays, Hrd1 linchpin mutations slow the first step below the
lower limit that would guarantee unimpeded protein degradation
(see Fig 3B—left panel). Therefore, we can unambiguously
conclude from experiments with the linchpin variants that linchpin-
mediated stimulation of Ubc7 by Hrd1 is involved in a rate-
determining step of protein degradation. But we cannot say whether
this is the priming step or the first step of chain elongation (or both)
based on the data for Hrd1 alone. As Doa10 uses different E2s for
the two steps in question, we turned to Doa10 for clarification.
The effects of Doa10 linchpin mutations on protein degradation
were assessed by introducing individual Doa10 variants in the
genomic DOA10 locus and analysis of protein degradation by CHX
decay assays. In stark contrast to the Hrd1 case, degradation rates of
Doa10 substrates are not altered for Doa10 linchpin variants (Fig 4A
—right panel). Similar to the case for the Cue1 mutant, the model
substrate FLAG-Sbh2 appears to be an exception, as its degradation
rates are decreased in strains carrying either Doa10(94R) or (94A).
However, degradation was still substantially faster than in the strain
deleted for Doa10 (Fig EV5A). The overall lack of effects in
observed degradation rates for Doa10 linchpin mutants implies that
these mutations do not slow chain elongation to an extent that
adversely affects protein degradation. But the Doa10 linchpin muta-
tions substantially impede the rate of the slowest mono-Ub to di-Ub
reaction in in vitro chain elongation reactions to well below the
threshold “minimal wt rates” (see Fig 3B—right panel). This means
that our previously specified lowest rate estimate for chain elonga-
tion can be seriously undercut without resulting in an observed
change in the rate of protein degradation observed in our assays.
Importantly, the rates observed for Hrd1 linchpin mutants are simi-
lar to those of Doa10 linchpin mutants for the first step of elongation
(see Fig 3B). Altogether, the results allow us to infer that Hrd1
linchpin mutants do not impede degradation rates through effects
on chain elongation. We therefore propose that priming is the E3-
dependent rate-determining step in protein degradation in the pres-
ence of Hrd1 linchpin variants.
Linchpin-mediated E2 stimulation is crucial for priming at Hrd1,
but not at Doa10
To test our hypothesis further, Hrd1 linchpin mutants were tested
for their ability to prime in the in vitro substrate ubiquitylation assay
(Fig 4B). In contrast to the robust RNase modification observed for
Ubc7 with wild-type S-Hrd1(400R), only faint or undetectable
RNase-Ub bands appeared with Hrd1 linchpin mutants. The concur-
rence of Hrd1 linchpin effects in both in vivo substrate degradation
assays and in vitro ubiquitylation assays is strong evidence that
priming of substrates and not Ub chain elongation is the slower and
thus rate-determining step for Hrd1-dependent ERAD substrate
degradation. The results also reveal that linchpin-mediated E2 stim-
ulation by Hrd1 is crucial for priming, but is dispensable for elonga-
tion in vivo. This is consistent with the ability of Doa10 with its
suboptimal linchpin to function effectively with Ubc7 in the chain
elongation stage of its substrate ubiquitylation process.
The apparent linchpin independence of Doa10 substrate degrada-
tion rates might suggest that its priming step is also linchpin-inde-
pendent. To test this hypothesis, we performed in vitro Ub
discharge assays of Doa10 linchpin mutants with Doa10’s preferred
priming E2, Ubc6. No clear correlation between linchpin identity
and ability to stimulate Ubc6 was observed (Fig 4C). Indeed, while
◀ Figure 3. Ubc7-mediated Ub chain elongation is not rate-determining for protein degradation.A In vitro Ub nucleophile discharge assays for U7BR/Ubc7 with indicated Hrd1 (left) and Doa10 (right) variants. E2 stimulation is shown as the ratio of rates derived
from RING-catalyzed reactions and the “no E3” control (see Fig EV2C and D). Values are reported as means  standard deviation (n = 3). Significances for pairwise
comparisons were determined by one-way ANOVA test; *P < 0.05. For clarity, only significances related to the “no E3” control are shown. In addition, reactions for
Hrd1(400R) and Doa10(94R) are significantly faster than all other reactions and the reaction for Doa10(94H) is significantly faster than that for Doa10(94E). The wild-
type E3s are identified by black frames for each set.
B In vitro Ub chain formation assay by Ubc7 with indicated Hrd1 (left) and Doa10 (right) variants in the presence of indicated Cue1 variants. Rates for reactions of
mono-Ub to di-Ub and di-Ub to tri-Ub with fluorescently labeled Ub are shown on a logarithmic scale. Values are reported as means  standard deviation (n = 3).
Significances for pairwise comparisons were determined by one-way ANOVA test; *P < 0.05. For clarity, only significances related to the “no E3” control of given
reaction set are shown.
C Steps of ERAD protein degradation with associated rate constants; S = ER protein; S* = misfolded protein, i.e., ERAD substrate; kobs = observed rate of protein
degradation in assays; kUb1 = rate of the priming reaction; kUb2 = rate of the first elongation step, i.e., mono-Ub to di-Ub; kUb3  kUbn = rates of subsequent
elongation steps; k0  kj = rates for other steps of ERAD; the black box identifies steps of substrate poly-ubiquitylation with priming highlighted by the green box
and chain elongation by the yellow box. The light yellow background highlights the mono-Ub to di-Ub reactions.
D Protein degradation in indicated yeast strains monitored by pulse-chase experiments for the Hrd1 model substrate PrA*-3xHA (left) and by CHX decay assays for the
Doa10 model substrate Deg1-eGFP2 (right). Values for each time point are reported as means  standard deviation (n = 4 for PrA*-3xHA and n = 3 for Deg1-eGFP2).
Source data are available online for this figure.
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the non-native arginine linchpin is most effective at stimulating
Ubc6 discharge, the wild-type histidine linchpin is least effective
and alanine and glutamate linchpins appear slightly more effective
than the wild-type. Moreover, Ubc6 stimulation does not show any
correlation with linchpin identity, when interacting with Hrd1
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an intrinsic feature of Ubc6. While this lack of linchpin dependency
appears congruent with the observation that degradation of Doa10-
dependent substrates is unaffected by Doa10 linchpin mutations
(see Fig 4A—right panel), we cannot rigorously conclude that the
priming step of Doa10-catalyzed substrate ubiquitylation is rate-
determining. The formal possibility that a step that does not involve
Doa10 is rate-determining for its substrate degradation cannot be
ruled out by the combination of in vivo degradation and in vitro
discharge assays for Doa10. Based on the fact that poly-ubiquityla-
tion and, specifically, priming by Ubc7 are rate-determining for
Hrd1-dependent degradation, it is likely that the same is true for
Doa10-dependent priming by Ubc6. Importantly, however, for both
Doa10 and Hrd1 substrate degradation, the Ubc7-dependent chain
elongation is not rate-determining.
Data presented thus far provide a rationale for why Ubc7 is not
the functional priming partner for Doa10. The question remains
how Doa10 is able to function with Ubc6. To assess how Ub transfer
to a substrate (as opposed to nucleophile) is affected by the Doa10
linchpin, we performed in vitro assays with both E2s and S-Doa10
linchpin variants (Fig 4D). When paired with Ubc7, only the hyper-
active Doa10(94R) variant produces product at a level significantly
above the “no E3” reaction. Thus, in this proxy for a priming reac-
tion, wild-type Doa10 is ineffective at stimulating Ubc7 to transfer
Ub to a substrate. In Ubc6 reactions, product bands of comparable
intensity were detected in all reactions containing Ubc6, including
the reaction with no E3 present. Hence, the assay does not provide
clarity regarding the linchpin contribution, or lack thereof, for prim-
ing reactions carried out by Ubc6. Nevertheless, the assay does reca-
pitulate the strong dependence of Ubc7 on an optimal linchpin.
Given the robust RNase modification observed for the S-Doa10(94R)
variant with Ubc7, it appears that the suboptimal wild-type histidine
linchpin of Doa10 actively disfavors use of Ubc7 for priming, leaving
the way clear for pairing with Ubc6.
In the substrate ubiquitylation assays (see Fig 4D), reactions
carried out in the absence of E3 reveal a difference between the abil-
ity of Ubc6 and Ubc7 to transfer Ub without E3 stimulation. While
no to little product was generated by Ubc7, product generated by
Ubc6 was clearly detected. Moreover, similar amounts of product
were generated in reactions that included Doa10. These observa-
tions suggest a scenario where priming can be carried out by Ubc6
without an absolute requirement that its Ub transfer activity be
stimulated by an E3. In contrast, regulation of the priming function
of Ubc7 appears to depend critically on its linchpin-dependent stim-
ulation by an E3 (as shown for Hrd1—see Fig 2).
The Ubc6~Ub conjugate populates closed conformations more
than other E2~Ub conjugates
The functional preference of Doa10 for Ubc6 over Ubc7 during prim-
ing could be determined solely by Ubc7’s dependence on an optimal
linchpin. But it raises the question of how Ubc6 circumvents the
disadvantage of Doa10’s suboptimal histidine linchpin. Several obser-
vations point to a high basal (i.e., non-E3-stimulated) activity for
Ubc6. First, Ubc6 has higher intrinsic ubiquitylation activity on the
proxy substrate RNase (compare “no E3” lanes between Ubc6 and
Ubc7 in Figs 2B and 4D). Second, the absolute rates of Ub discharge
onto ethanolamine in the absence of an E3 are higher for Ubc6
compared to U7BR/Ubc7 (compare “no E3” controls in Figs EV2C
and D with EV2E and F). This observation must be interpreted with
care due to the bi-functional nature of ethanolamine and the different
reactivity profiles of the two E2s. Third, the rates of hydrolysis (i.e.,
Ub discharge via H2O) of Ubc6 and U7BR/Ubc7 conjugates are vastly
different (Fig 5A). And although reactivity profile differences may
play a role in this case too, stability toward hydrolysis has been used
as a general measure of E2 reactivity (Pruneda et al, 2011; Plechano-
vová et al, 2012). In sum, the observations indicate that Ubc6~Ub
has higher intrinsic reactivity than Ubc7~Ub.
To understand the source of Ubc6’s higher intrinsic activity,
disulfide-linked Ub conjugates of both E2s were characterized by
NMR. We focused on the spectral properties of the common
subunit, i.e., Ub, in the two species, collecting NMR spectra on
samples in which only the Ub subunit was isotopically labeled
◀ Figure 4. Linchpin-mediated E2 stimulation is crucial for priming at Hrd1, but not at Doa10.A Protein degradation in indicated yeast strains monitored by pulse-chase experiments for the Hrd1 model substrate PrA*-3xHA (left) and by CHX decay assays for the
Doa10 model substrate Deg1-eGFP2 (right). Values for each time point are reported as means  standard deviation (n = 4 for PrA*-3xHA and n = 3 for Deg1-eGFP2).
Data for control strains (Hrd1(400R) wt, Dhrd1, Doa10(94H) wt, and Ddoa10) are the same as in Fig 3D. A side-by-side comparison of protein degradation in all tested
strains is shown in Appendix Figs S1 and S2.
B In vitro substrate ubiquitylation assay for Hrd1 variants with Ubc7. Ubc7 reactions contained equimolar amounts of Cue1 and were performed with Ub(K48R). Top:
Representative immunoblot using a poly-clonal a-RNase A antibody; “no E3” reaction does not contain any S-Hrd1, “no ATP” reaction does not contain ATP, but wild-
type S-Hrd1(400R). The RNase-Ub2 band co-migrates with a non-specific band (#) common to all samples. Bottom: Quantification of RNase-Ub signals is shown.
Values are reported as means  standard deviation (n = 3). Significances for pairwise comparisons were determined by one-way ANOVA test; *P < 0.05. For clarity,
only significances related to the “no E3” control are shown. In addition, the reaction containing S-Hrd1(400R) shows significantly more ubiquitylation than those
with other E3 variants.
C In vitro Ub nucleophile discharge assays for Ubc6 with indicated Doa10 variants. E2 stimulation is shown as the ratio of rates derived from RING-catalyzed reactions
and the “no E3” control (see Fig EV2E). Values are reported as means  standard deviation (n = 3). Significances for pairwise comparisons were determined by one-
way ANOVA test; *P < 0.05. For clarity, only significances related to the “no E3” control are shown. In addition, the reaction for Doa10(94R) is significantly faster than
that for Doa10(94H) and (94E). The wild-type E3 is identified by a black frame. The scale of the y-axis was set identical to that of plots from other discharge assays
(see Figs 2E and 3A) for easier comparison.
D In vitro substrate ubiquitylation assay for Doa10 variants with Ubc7 (left) and Ubc6 (right). Ubc7 reactions contained equimolar amounts of Cue1 and were
performed with Ub(K48R). Top: Representative immunoblot using a poly-clonal a-RNase A antibody; “no E3” reaction does not contain any S-Doa10, “no ATP” reaction
does not contain ATP, but wild-type S-Doa10(94H). The RNase-Ub2 band co-migrates with a non-specific band (#) common to all samples. Bottom: Quantification of
RNase-Ub signals is shown. Values are reported as means  standard deviation (n = 3). Significances for pairwise comparisons were determined by one-way ANOVA
test; *P < 0.05. For clarity, only significances related to the “no E3” control of a given E2 are shown. In addition, the reaction containing Ubc7 and S-Hrd1(400R)
shows significantly more ubiquitylation than those with Ubc7 and other E3 variants.
Source data are available online for this figure.
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(E2-SS-(15N)Ub). The spectra of Ub in the context of each conjugate
were compared to the spectrum of free Ub, and differences are
reported as chemical shift perturbations (CSPs). It has been estab-
lished for other E2~Ub species that the more Ub inhabits “open”
conformations, the closer its spectrum will resemble that of free Ub
(i.e., small CSPs) (Hamilton et al, 2001; Pruneda et al, 2011, 2012;
Wickliffe et al, 2011; Choi et al, 2015; Dove et al, 2016). As the
populations or lifetimes of closed conformations increase, observed
CSPs on Ub increase due to the altered chemical environment at the
E2/Ub interface. Ub CSPs that center around Leu8, Ile44, Val70, and
the C-terminal tail are observed in both the Ubc6 and Ubc7 conju-
gates (Fig 5B). Leu8, Ile44, and Val70 define the Ub hydrophobic
patch that interacts with an E2 in reactive closed conformations (see
Fig 1B), and the C-terminal residues link Ub to the E2 active site.
The striking difference between the two conjugates is the very
large magnitude of Ub CSPs in the Ubc6 conjugate (Fig 5B and
Appendix Figs S3 and S4), which are easily among the largest
published to date. Seven peaks are either lost due to exchange
broadening or shift to an extent that they cannot be assigned with
confidence in the spectrum of Ubc6-SS-(15N)Ub as compared with
only one such perturbation in the U7BR/Ubc7-SS-(15N)Ub spec-
trum. The data reveal that Ub conjugated to Ubc6 experiences
environments that are more dissimilar to free Ub than Ub in conju-
gates of Ubc7 or other E2s studied to date (see spectral insets in
Fig 5B and Appendix Fig S3 and examples in Choi et al, 2015;
Dove et al, 2016; Pruneda et al, 2011). This is strong evidence that
a greater population of Ubc6~Ub resides in closed conformations
compared to other E2~Ub conjugates and particularly Ubc7~Ub in
the absence of an E3 ligase.
15N relaxation parameters were measured as an independent
assessment of Ub in different conjugates. Ratios of 15N relaxation
times, T1/T2 (Fig 5C), provide a metric for how flexible Ub is in
each conjugate (Pruneda et al, 2011). For globular proteins, T1/T2
ratios scale with molecular weight, as they report on molecular
tumbling time. Despite Ubc6 having a lower molecular weight than
U7BR/Ubc7, their conjugated Ubs’ average T1/T2 values are similar
(39.5  8.2 vs. 36.6  9.8, respectively; Fig 5C). For context, T1/
T2 ratios were also determined for Ub attached to human Ubc13
which is much closer in molecular weight to Ubc6 than U7BR/Ubc7.
Here, the much smaller average ratio (18.2  3.9) is congruent with
a highly flexible Ub that predominantly inhabits a myriad of open
conformations, as established previously by other techniques
(Pruneda et al, 2011). Taken together, these values are strong
evidence that Ub attached to Ubc6 spends more time in conforma-
tions in which the conjugate tumbles as a single unit rather than
two tethered but independent molecular entities. In combination
with the large CSPs observed at Ub’s hydrophobic patch, the relaxa-
tion data strongly support the notion that the Ubc6~Ub conjugate is
more biased toward closed conformations than those of other E2s.
A bias toward closed conformations is important for two reasons:
first, it is consistent with the greater intrinsic Ub transfer activity we
observed for Ubc6~Ub, as closed conformations are generally associ-
ated with increased reactivity. In line with this is the observation that
E3s only modestly stimulate Ubc6 from its already high basal activity
as compared to Ubc7 (see Fig EV2G). Second, the closed conforma-
tion bias of Ubc6~Ub helps explain why the conjugate is less depen-
dent on allosteric stimulation via a RING linchpin than Ubc7~Ub. The
results thus provide an explanation for why Ubc6 does not strictly
rely on a linchpin and, consequently, how Doa10 with its suboptimal
linchpin is able to pair functionally with Ubc6 for priming.
Versatility in ERAD priming E2 usage
Despite their established E2 preferences, we have shown that both
ERAD E3s can work with their non-preferred priming E2, at least
in vitro. This raises the question as to whether there is some cross-
over of priming E2 utilization in vivo. To address this point, we
examined ERAD substrate turnover in cells that lack either Ubc6 or
Ubc7. Consistent with the essential role of Ubc7 in the Ub chain
elongation step, degradation of most substrates monitored is abol-
ished in cells lacking Ubc7 to levels of cells deleted for the E3 ligases
(Figs 6A–C and EV4C—compare solid and dotted curves). Hmg2-
6xMyc (Fig EV4C) and Deg1-eGFP2 (Fig 6B) degradation still occurs
in Dubc7 strains, as it does in Dhrd1 and Ddoa10 strains, respec-
tively (see also Fig 3D), suggesting an alternative pathway of
protein quality control for these substrates. As predicted, deletion of
UBC6 has no effect on degradation of Hrd1 model substrates
(Figs 6D and EV4D—compare solid and dashed blue curves).
However, in strains expressing a suboptimal, Doa10-like Hrd1 linch-
pin mutant (400H), deletion of UBC6 has a slight adverse impact on
the degradation of the Hrd1 model substrate PrA*-3xHA (Fig 6D—
compare solid and dashed green curves). In this Hrd1 hypomorphic
setting, the absence of Ubc6 impairs degradation to the level of
strains lacking Hrd1 altogether. A similar, though less pronounced
trend was detected for Hmg2-6xMyc degradation (Fig EV4D). These
observations imply that Hrd1 can use Ubc6 for priming in vivo at
least to a small degree and/or under extreme conditions.
To pursue the potential of Ubc6 priming at Hrd1 further, we
turned to published evidence that genetically linked Ubc6 to Hrd1
for degradation of its model substrate, CPY* (Hiller et al, 1996). To
◀ Figure 5. The Ubc6~Ub conjugate populates closed conformations more than other E2~Ub conjugates.A E2~Ub hydrolysis assays for U7BR/Ubc7 and Ubc6. E3-independent Ub discharge assays for both E2s in PBS (absence of nucleophile = hydrolysis) were performed at
32°C. Left: Representative Coomassie gels. Right: Plots of E2~Ub hydrolysis (dots) as a function of time with first-order reaction models fitted to the discharge data
(lines) are shown. Values for each time point are reported as mean  standard deviation (n = 3).
B HSQC-TROSY experiments comparing free and E2-conjugated (15N)Ub. Top: CSPs of (15N)Ub(G76C) conjugated to indicated E2s via disulfide bond (775 lM each)
compared to free (15N)Ub(G76C) are shown; Ub residues known to be involved in the closed conformation interface are underlined in gray; *number of resonances
with perturbations too large to be assigned confidently (shown as off-scale in diagram). Bottom: Spectra of resonances for selected residues in Ub’s hydrophobic
patch for free Ub(G76C) (gray) and Ub conjugated to Ubc6 (green) and U7BR/Ubc7 (yellow).
C Summary of T1 and T2 relaxation analysis for (15N)Ub(G76C) in various E2 conjugates. The table shows the mean T1/T2 ratios  standard deviation over all Ub peaks
in a given conjugate (or for the free protein) as well as their molecular weights. Bottom: Cartoons depict open/closed conformation equilibria for different conjugates.
Source data are available online for this figure.
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confirm involvement of Ubc6 unambiguously, we leveraged the abil-
ity of this E2 to transfer Ub to hydroxyl-containing side chains
(Weber et al, 2016) by using a lysine-less version of CPY* (“CPY*-
K0-HA”) (Baldridge & Rapoport, 2016). We confirmed that CPY*-
K0-HA is not a substrate for Doa10, as its degradation rate is not
affected by deletion of DOA10 (Fig 6E—compare black vs. purple
curves). Nevertheless, deletion of UBC6 is as detrimental as deletion
of HRD1 or introduction of a catalytically dead version of Ubc7
(C89S) (Fig 6E—compare green vs. blue and yellow curves).
Furthermore, simultaneous deletion of HRD1 and UBC6 does not
result in an additional effect (Fig 6E—compare green vs. gray
curves), suggesting Hrd1 and Ubc6 function in the same pathway
for this substrate. Thus, the model Hrd1 substrate can be primed by
Ubc6 in its hydroxyl-reactive mode.
In a similar vein, we asked whether Doa10 substrates can be
primed by Ubc7, despite the suboptimal linchpin. As predicted by
the functional pairing of Ubc6 and Doa10, we observed a negative
impact on the degradation of Doa10 model substrates with deletion
of UBC6 (Fig 6B and F—compare solid vs. dashed green curves).
Degradation of the Doa10 model substrate Deg1-eGFP2 is impaired
to similar levels in cells deleted for DOA10 or UBC6 (Fig 6B), illus-
trating that processing of this Doa10 substrate is strictly dependent
on priming by Ubc6. However, cells that lack Ubc6 are still able to
turnover FLAG-Sbh2, the other Doa10 model substrate studied here,
albeit at a slower rate than when the favored priming E2 is present
(Fig 6F—compare solid and dashed green curves). This suggests
that Ubc7 can carry out priming at Doa10 E3 ligase. However, when
we repeated the experiment in a yeast strain that lacks Ubc6 and
expresses the Ubc7-activating Doa10(94R) variant, we did not
observe improved FLAG-Sbh2 turnover (Fig 6F—compare dashed
green and blue curves). Curiously, in a strain that expresses Ubc6
and the hyperactive Doa10(94R) variant, FLAG-Sbh2 degradation is
even slightly impaired (Fig 6F—compare solid green and blue
curves) suggesting that in vivo the situation is more complex and
Doa10 cannot switch seamlessly between priming E2s depending on
its linchpin. Nevertheless, the data illustrate that “suboptimal” E2/
E3 pairings are possible and can carry out priming reactions in cells.
Discussion
In protein poly-ubiquitylation, a distinction between the priming step
of mono-ubiquitylation and subsequent elongation steps of poly-Ub
chain building is conceptually acknowledged. The notion that these
distinct processes would be carried out by different E2s was slow to
be embraced, but is now well established for multiple systems
(Rodrigo-Brenni & Morgan, 2007; Parker & Ulrich, 2009; Wu et al,
2010a; Weber et al, 2016). For many systems, however, the identity
of the relevant priming E2(s) remains unexplored and even in cases
where the complete set of E2s that can function with a given E3 is
known, which pairing(s) are functionally relevant in a given cellular
situation is not. For example, the heterodimeric RING E3, BRCA1/
BARD1, was shown to work with five priming E2s and three elongat-
ing E2s (Christensen et al, 2007), but the pairings relevant for cellu-
lar function remain to be determined. Lack of specific information
regarding which E2 is used by which E3 for which substrate and for
which functions (priming and/or elongation) have impeded efforts
to understand functional E2/E3 interplay in greater detail.
As it has been so thoroughly studied, the ERAD poly-ubiquityla-
tion system provided a powerful way to address the question of
how an E3 pairs with its preferred E2(s) for priming and elonga-
tion. Several features of the ERAD system were key. First, its two
E3 ligases have non-overlapping substrate specificities: Hrd1
mainly targets proteins with lesions in their luminal or membrane
domains, while Doa10 predominantly degrades proteins with
cytosolic lesions (Ruggiano et al, 2014). This allowed us to moni-
tor the effects of perturbations on substrates of one or the other
E3. Second, the two E3s use the same chain-elongating E2, Ubc7,
but differ in their choice of priming E2. Third, both E3 ligases
retain the ability to pair with the non-preferred E2 for priming
(i.e., Hrd1 with Ubc6 and Doa10 with Ubc7). While this property
can confound interpretation of in vivo studies, it provided impor-
tant controls in our investigation.
Through a combination of in vitro and in vivo experiments, we
have determined the mechanism how each of the ERAD RING E3
ligases utilizes their preferred E2 enzyme during priming. Hrd1
selects Ubc7 over Ubc6 through higher binding affinity: a mecha-
nism we dub “affinity-driven pairing”. The greater than one order-
of-magnitude difference in affinity guarantees that a given Hrd1
RING will engage Ubc7~Ub more frequently and with a longer life-
time than a similarly disposed Ubc6~Ub, particularly because both
E2s appear to be expressed at roughly similar levels [according to
PaxDb—(Wang et al, 2015) and (Clague et al, 2015)]. Further-
more, Hrd1 binding stimulates the Ub transfer activity of Ubc7
better than it does Ubc6 (see Fig 2E). Together, the affinity and
subsequent stimulation provide a strong selective preference of
Hrd1 for Ubc7 (Fig 7—top). This is in line with the previously
reported differential stimulation of Ubc7 by Hrd1 and Doa10
(Cohen et al, 2015). Thus, Hrd1 seems to follow the classical E3
dualism of using its E2 recruitment and stimulation function to
control the priming reaction.
In contrast, Doa10 collaborates with different E2s for priming
and elongation and does not seem to differentiate between the two
based on affinity. Our study reveals that Doa10’s use of Ubc6
during priming is established through a mechanism we call “rate-
driven pairing” (Fig 7—bottom). It relies on two features: (i)
Doa10’s suboptimal histidine linchpin residue, with which the E3
largely abdicates its E2 stimulation function and thus disfavors
collaboration with Ubc7 and (ii) Ubc6’s relative linchpin insensi-
tivity, which allows its utilization by Doa10 despite its suboptimal
linchpin. The linchpin insensitivity stems from Ubc6’s high basal
activity due to the adoption of reactive closed conformations of its
conjugate; hence, the E2 undergoes only moderate stimulation by
either E3 in vitro. High E3-independent Ubc6 activity might pose a
danger to a cell through ubiquitylation events that are outside of
E3 control (as exemplified in vitro for the E3-independent ubiquity-
lation of RNase by Ubc6—see Fig 2B). We speculate that the
reported constitutive auto-ubiquitylation of Ubc6 is a symptom of
this as well as a means to keep this danger in check, as the auto-
modification is Doa10-independent (Weber et al, 2016) and leads
to rapid Ubc6 degradation in the absence of an ERAD substrate
(Walter et al, 2001). Such a regulatory mechanism would fit with
our finding that Ubc6 is a highly active E2 and underscores the
importance of the substrate recruitment function of Doa10 as
opposed to its stimulation function as means of spatiotemporal
control of the priming reaction on an E3-bound substrate.
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Integral to the rate-driven pairing mechanism for Doa10 and
Ubc6 is our finding that the suboptimal linchpin of the RING does
not handicap its ability to use Ubc7 for subsequent Ub chain elon-
gation reactions. The Doa10/Ubc7 pair achieves rates of chain
elongation on par with those of the high-affinity Hrd1/Ubc7 pair
in vitro (see Fig 3B). Moreover, we could show that Ubc7-mediated
chain elongation is comparably fast and thus is not rate-deter-
mining to the overall process of ERAD substrate degradation.
Linchpin-mediated Ubc7 stimulation by the RINGs and chain align-
ment by Cue1 play a role in boosting elongation rates. Yet even
their disruption (through linchpin mutation or the Cue1(RGA)
mutant, respectively) does not slow elongation to a level where it
might become rate-determining for protein degradation. Our work
thus provides an explanation for the previously reported, yet unex-
plained discrepancy between the defect that Cue1(RGA) causes in
the in vitro situation and its apparent lack of an effect on protein
degradation in vivo (Bagola et al, 2013; von Delbrück et al, 2016).
Overall, our results demonstrate that, while the components
involved in the elongation reaction each contribute to optimizing
the process, chain elongation itself is not rate-determining to the
ultimate biological outcome of protein degradation.
Our investigation adds the ERAD system to those poly-ubiquity-
lation systems that have been studied to a level of detail that
provides kinetic insights on the different steps. Most prominent
among these systems are the mitotic master-regulator RING E3
complex APC/C (Rodrigo-Brenni & Morgan, 2007; Jin et al, 2008;
Summers et al, 2008; Garnett et al, 2009; Williamson et al, 2009;
Wu et al, 2010b; Brown et al, 2014, 2015; Kelly et al, 2014; Chang
et al, 2015; Lu et al, 2015) and the SCF RING E3 ligases complexes
(Kleiger et al, 2009; Wu et al, 2010a; Emberley et al, 2012; Pierce
et al, 2013). For the latter example, millisecond kinetic measure-
ments revealed that most enzyme–substrate encounters with the
SCF ligase are non-productive due to the low rate of the first Ub
transfer, while rates of sequential Ub additions were markedly faster
than substrate dissociation (Pierce et al, 2009). Qualitatively, this
kinetic dichotomy is reminiscent of the one we found in the ERAD
system.
As seen previously, we find that Hrd1’s selection of Ubc7 and
Doa10’s pairing with Ubc6 during priming is essential for robust
substrate degradation in vivo (Figs 6 and EV4F; Weber et al, 2016).
We also found that the ERAD E3s retain the ability to collaborate
with their non-preferred E2 for priming. Our work provides a
◀ Figure 6. Versatility in ERAD priming E2 usage.A–F Protein degradation in indicated yeast strains monitored by pulse-chase experiments for the Hrd1 model substrates PrA*-3xHA (A and D) and lysine-less CPY*-K0-
HA (E) and by CHX decay assays for the Doa10 model substrates Deg1-eGFP2 (B) and FLAG-Sbh2 (C and F). Values for each time point are reported as
means  standard deviation (n = 4 for PrA*-3xHA and n = 3 for Deg1-eGFP2 and FLAG-Sbh2, respectively). For A, data for control strains (Hrd1(400R) wt, Hrd1
(400H), and Dhrd1) are the same as in Figs 3D and 4A. For D, data for control strains (Doa10(94H) wt and Ddoa10) are the same as in Figs 3D and 4A. A side-by-
side comparison of protein degradation in all tested strains is shown in Figs EV4 and EV5 and Appendix Figs S1 and S2.
Source data are available online for this figure.
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Figure 7. Model for E2 utilization by Hrd1 and Doa10.
Hrd1 uses Ubc7 for both priming and elongation and selects Ubc7 over Ubc6 for priming through higher binding affinity and optimal stimulation through its arginine
linchpin (“affinity-driven pairing”). Doa10 uses Ubc6 for priming. Although it binds the conjugates of the two E2s with similar affinity, its suboptimal histidine linchpin is
ineffective at stimulating Ubc7. In contrast, Doa10 pairing with Ubc6 is highly active due to the high basal activity of Ubc6~Ub that does not require substantial stimulation
by a linchpin. We call this mode of E2 selection “rate-driven pairing”. E3-mediated E2 stimulation is dispensable during elongation, allowing Doa10 to pair productively with
Ubc7. For later elongation steps, Cue1 plays an important role in driving reaction rates although Ub chain elongation is generally not rate-determining for the kinetics of
protein degradation. Finally, both RINGs retain the ability to use the non-preferred E2 for priming (dashed arrows), possibly providing a “backup mechanism” for priming.
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mechanistic framework for how preferred E2/E3 pairings are estab-
lished but does not answer the question why these preferences are
functionally important for ERAD substrate degradation. Using the
linchpin dependencies uncovered, we could alter the E2/E3 pairings
in vitro. For example, switching the Doa10 linchpin to arginine
creates an E3 that can efficiently ubiquitylate the substrate proxy
RNase via Ubc7 (see Fig 4D). Likewise, swapping Hrd1’s linchpin to
histidine disables its ability to stimulate Ubc7 (see Fig 3A), while its
Ubc6 stimulation remains virtually unchanged (see Fig EV2G). But
the same mutations do not translate into a seamless switch of prim-
ing E2 preference when viewed through the lens of protein degrada-
tion in vivo: While the Hrd1(400H) variant renders Hrd1 substrate
degradation somewhat Ubc6-dependent (see Figs 6D and EV4D), it
was still less efficient than with wild-type Hrd1(400R), which
entirely depends on Ubc7. Similarly, degradation of Doa10 model
substrates did not become Ubc6-independent in strains that carry
the Ubc7-amiable Doa10(94R) mutant (see Fig EV5D and
Appendix Fig S2D). Clearly, there is more to priming E2 preference
than the effectiveness of an E3’s linchpin, e.g., ternary interactions
between the E3 ligase, its preferred E2 conjugate, and a specific
substrate. Thus, correct E2/E3 pairing for priming fundamentally
matters for efficient substrate degradation. As to the ability of both
E3s to potentially use their non-preferred E2 for priming, we specu-
late that it might work as a failsafe mechanism under extreme
conditions, e.g., Hrd1’s use of Ubc6 for substrates with few or inac-
cessible lysines (see Fig 6E).
To summarize, we have provided a mechanistic and conceptual
framework for how ERAD RING E3s exploit different stimulation
requirements of their cognate E2s to pair with them for a specific
function. Although the rate-driven pairing model described here is
based on the idiosyncratic properties of Ubc6 and might therefore
be specific to the ERAD system, our work sheds light into an impor-
tant and largely overlooked question: Why do a substantial fraction
of RING domains feature a residue at the linchpin position that is
suboptimal to arginine or cannot hydrogen bond (60% in yeast—
Fig 1C, 53% in humans—Fig EV1), when such an interaction is
thought to be crucial for stimulating a collaborating E2? Our work
suggests a picture where the E2 stimulation function of RING E3s
may not be absolutely crucial to control ubiquitylation in all
instances. E2s may have different stimulation requirements thus
providing RINGs with the opportunity to regulate pairing with speci-
fic E2 counterparts for a desired functional outcome.
Most E2s characterized to date have conjugates that exist
predominantly in open (less reactive) conformations, thereby
implying linchpin sensitivity. But a majority of E2~Ub species have
yet to be characterized (Stewart et al, 2016). Given the large frac-
tion of RING E3s that harbor suboptimal linchpins, it is not unrea-
sonable to propose a spectrum of E2~Ub behaviors that span from
predominantly open and highly linchpin-dependent, like in the
case of Ubc7 (shown here) or human UbcH5 (Pruneda et al, 2011)
to more closed conjugates, like that of Ubc6 (shown here) or
human Ube2G1 (Choi et al, 2015), which may show higher basal
activity and be linchpin-insensitive. RING E3s will have evolved to
take advantage of such differences and to “thread the needle” if
their biological functions require them to pair with more than one
E2. For example, Rbx1, the RING module of all CRLs, has aspara-
gine as its linchpin in both yeast and humans. CRLs control the
degradation of about a fifth of all proteasome-dependent
degradation (Soucy et al, 2009) raising the question as to why
their RING does not provide the most efficient linchpin. Previous
work showed that the asparagine linchpin in Rbx1 is actually
superior to arginine in its ability to stimulate both the idiosyncratic
chain building E2, Cdc34, and the functionally essential NEDD8-
specific E2, Ubc12 (Scott et al, 2014). However, the asparagine
linchpin is, as expected, less efficient than arginine at stimulating
Ub transfer activity from UbcH5. CRLs have been shown to stimu-
late E2s of the UbcH5 family in addition to Cdc34 (Duda et al,
2008; Saha & Deshaies, 2008; Yamoah et al, 2008) and potentially
use the former for priming (Wu et al, 2010a). But in an additional
wrinkle, the priming reaction for many CRL substrates in vivo is
carried out by the RBR (RING-between-RING) E3 ligase ARIH1 and
its cognate E2 UbcH7 (Scott et al, 2016; Dove et al, 2017), which
rely on a different molecular mechanism from RING E3s and their
E2s (Wenzel et al, 2011). Analogous to the ERAD cases studied
here, we speculate that the non-optimal linchpin of Rbx1 disfavors
priming reactions catalyzed by Rbx1, thus promoting the preferred
priming action of the ARIH1/UbcH7 pair.
Finally, we further extend our insights to another class of E3
ligases that choose from the same pool of E2s as RING E3s, specifi-
cally, the aforementioned RING-Between-RING (RBR) E3s. The idea
that RINGs have evolved suboptimal linchpins for functional
reasons has been invoked in the context of RBR E3 ligases. Despite
containing an E2-recruiting RING domain, RBR E3s work via an
E3~Ub thioester intermediate that subsequently modifies a substrate
(Wenzel et al, 2011). Here, the RBR RING1 domain sterically disfa-
vors closed E2~Ub conformations (Dove et al, 2016). Maintaining
the bound E2~Ub in an open, unreactive conformation prevents
premature Ub discharge from the E2 onto nearby (E3) lysine resi-
dues. Indeed, no human or yeast RBR features an arginine at the
linchpin position. We expect there are variations on the themes
revealed from our work and look forward to future studies that shed
light on other E3 ligases and particularly on E2s to better understand
their functional pairing mechanisms.
Materials and Methods
Plasmids, protein expression, and purification
Plasmid constructs, expression, and purification of most proteins
have been previously described (see Appendix Table S1). Ubc7
containing only the catalytic cysteine (“C89only” = C39A/C141S),
and the U7BR domain of Cue1 (aa 150–203) and Hrd1 (aa 325–412)
were cloned into a pET28a vector containing human His6-tagged
SUMO3, respectively (Meulmeester et al, 2008); Doa10 (aa 19–102)
was cloned into a pGEX-6p1 vector. Using constructs described
above, S-peptide-tagged variants of all RING E3 ligases were
obtained by cloning. All indicated mutants were created by site-
directed mutagenesis. For expression, plasmids were transformed in
BL21/DE3 bacteria and grown either in rich LB medium, TB
medium, or minimal MOPS medium supplemented with (15N)am-
monium chloride. Proteins were expressed overnight at 16°C after
induction at OD 0.6–0.8 with 1 mM IPTG. Recombinant proteins
were enriched via affinity chromatography using Glutathione
Sepharose or Ni-NTA for GST-tagged or His6-tagged proteins,
respectively. Depending on the construct, proteins were eluted by
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imidazole or cleavage with GST-HRV-3C protease, SUMO protease
(His6-Ulp1 or GST-tagged, catalytic fragment of hSENP1), or throm-
bin (Sigma). U7BR was purified by incubation with thrombin and
GST-hSENP1 after binding to Ni-NTA, followed by a washing step
and imidazole elution. All proteins were subjected to Superdex 75
size exclusion chromatography as the final step of purification.
Generation and purification of recombinant protein complexes
and adducts
Labeling of Ub(S20C) with Alexa Fluor 488 C5 maleimide was previ-
ously described (Bagola et al, 2013). K48-linked Ub chains (His6-
Ub2 and His6-Ub3) were assembled as previously described (von
Delbrück et al, 2016). The U7BR/Ubc7(C89only) complexes used
for NMR as well as the U7BR/Ubc7(wt) complexes used for in vitro
Ub discharge assays were purified by mixing purified Ubc7 and
U7BR in a 1:2 ratio and subjecting them to Superdex 75 size exclu-
sion chromatography. Disulfide-linked E2-SS-Ub conjugates were
obtained by incubating at least 200 lM of desired single-cysteine E2
variants (Ubc6 and Ubc13 naturally contain only one cysteine) with
a twofold molar excess of a disulfide-linked adduct of Ub(G76C) and
2-nitro-5-thiobenzoate (TNB) for 45 min at RT followed by
Superdex 75 size exclusion chromatography. The Ub(G76C)-TNB
adduct was prepared prior to conjugate formation by incubating
1 mM Ub(G76C) with 10 mM DTNB (Ellman’s reagent—Sigma)
followed by buffer exchange over Sephadex G-25 resin.
Isothermal calorimetry
Measurements were performed on a Microcal VP-ITC calorimeter
(Malvern Panalytical) at 15°C. Proteins were dissolved in PBS (25
mM sodium phosphate pH 7.0, 150 mM NaCl). Binding information
was obtained with 5 ll additions of titrant (Doa10 or Hrd1 at
3.5 mM) in 4-min intervals into 50 lM indicated E2-SS-Ub samples.
Data were analyzed using Microcal PEAQ-ITC analysis software
(Malvern Panalytical).
In vitro substrate ubiquitylation assay
The experimental setup was modified from Bays et al (2001). In
detail, reactions included E1 (300 nM), indicated E2 (5 lM each; for
reactions that contain free Ubc7, 5 lM Cue1(wt) was added as
well), indicated S-peptide-tagged RING variants (5 lM), RNase S
(5 lM), and Ub (wild-type or K48R for Ubc6 and Ubc7, respectively,
at 50 lM) in in vitro reaction buffer (50 mM Tris–HCl, pH 8.0,
4 mM MgCl2, 0.5 mM DTT). Reactions were started by the addition
of 4 mM ATP and incubated at 30°C for 30 min. Modification was
analyzed by immunoblotting against RNase A. Signals were visual-
ized on a Li-COR Odyssey system. Reactions were performed in trip-
licates. For each reaction, the RNase-Ub signal was quantified and
normalized by the total signal, i.e., signal of RNase and RNase-Ub
(RNase-Ub2 signals were not quantified as they are often negligible
and coincide with an unspecific signal).
In vitro Ub discharge assays
In vitro Ub discharge assays were performed similar to the proto-
col described in Wenzel et al (2011). The assay allows monitoring
the kinetics of Ub transfer from a preformed E2~Ub conjugate onto
a small nucleophile (Pickart & Rose, 1985; Wenzel et al, 2011). To
enable investigation of both Ubc7 and Ubc6 activation, we chose
ethanolamine as the nucleophile in light of the reported hydroxy-
reactivity of Ubc6 (Wang et al, 2009; Weber et al, 2016). Similar
to substrate proteins encountered by these E2s, ethanolamine
provides a primary amine and a hydroxyl group as potential nucle-
ophiles. Although the bi-functional substrate renders direct quanti-
tative comparison between Ubc6 and Ubc7 discharge kinetics
difficult due to the potentially different products formed by the
two E2s, it allows for uniform assay conditions and, for a given
E2, for comparison of E2 stimulation by different E3 ligases. For
the assay, indicated E2s (30 lM) were charged with Ub (120 lM)
in the presence of human E1 (3 lM for Ubc6 or 500 nM for Ubc7)
and 5 mM ATP at 37°C for 3 min. To assay Ubc6 activity, purified
Ubc6 (aa 2–179) was used. To assay Ubc7 activity, purified
complex of U7BR/Ubc7 was charged with Ub(K48R) to avoid
intrinsic chain formation. Charging reactions were quenched with
10 mM EDTA and, to start discharge, directly diluted 1:1 into PBS
containing ethanolamine (100 mM final concentration) and indi-
cated E3 ligases (30 lM final concentration). Reactivity time
courses were performed at RT, if not indicated otherwise. Samples
were quenched in non-reducing sample buffer at indicated time
points and visualized by Coomassie-stained SDS–PAGE. For each
time point, the band intensity for the E2~Ub conjugate and the
free E2 were determined by densitometry analysis using Gel Doc
EZ Imager (Bio-Rad) and the Image Lab 6.0.1 software (Bio-Rad).
Discharge was quantified by plotting over time the intensity of the
E2~Ub conjugate band divided by the sum of the intensities of
the E2~Ub conjugate and the free E2 band. Reaction rates were
derived by fitting discharge to a first-order reaction model using
xcrvfit. Reactions were performed in triplicates and presented rates
given as the mean of all replicates  standard deviation.
In vitro chain elongation reactions
Single-turnover chain elongation reactions included human E1
(150 nM), indicated Cue1 variants (2 lM), free Ubc7 (2 lM), indi-
cated E3 ligase variants (2 lM), acceptor Ub (C-terminally His6-
blocked mono-Ub or indicated K48-linked Ub chains at 14.8 lM
each), and donor Ub (fluorescent Ub(S20C)-C5 at 200 nM) in
in vitro reaction buffer. Reactions were started by the addition of
4 mM ATP and incubated at 30°C. Samples were quenched in
reducing sample buffer after 0, 1, 2, 3, 4, 5, 10, 30, and 60 min and
visualized by SDS–PAGE. Product formation over time was quanti-
fied by fluorescence at 488 nm using a Typhoon FLA9500 (GE
Healthcare) and ImageQuant TL 7.01 software (GE Healthcare).
Reaction rates were derived by fitting discharge to a first-order
reaction model using GraphPad Prism 6 software. Reactions were
performed in triplicates and presented rates given as the mean of
all replicates  standard deviation.
Yeast strains
All strains are haploid descendants of DF5 (trp1-1 (am)/trp1-1 (am),
his3-D200/his3-D200, ura3-52/ura3-52, lys2-801/lys2-801, leu2-3,
-112/leu2-3, -112, MATa/a) (Finley et al, 1987). Strains were
generated by standard transformation or crossing protocols.
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Appendix Tables S2 and S3 list the yeast expression plasmids and
yeast strains, respectively, used in this study. Appendix Fig S5
shows a validation of yeast strains.
Cycloheximide decay assay
Cycloheximide decay assays were performed as previously
described (Weber et al, 2016). In brief, log-phase growing yeast
cells were resuspended in cycloheximide-containing SD medium
(Sigma, final concentration: 0.33 mg/ml). At indicated time
points, samples were collected and degradation was stopped by
the addition of 10 mM sodium azide. Cell lysates were prepared
by the addition of glass beads and vigorous shaking. Samples
were analyzed by immunoblotting. Appendix Table S4 lists the
antibodies used for immunoblotting. For means of quantification,
fluorescently labeled secondary antibodies were used and visual-
ized on a Li-COR Odyssey system. Experiments were performed
in triplicates.
Pulse-chase assay
Pulse-chase assays were performed as previously described (Mehn-
ert et al, 2014). In brief, log-phase growing yeast cells were resus-
pended in SD medium. Newly synthesized proteins were labeled
with radioisotopes by the addition of 3 MBq EasyTagTM EXPRESS35S
Protein Labeling Mix (PerkinElmer, Inc.) and incubated at 30°C for
8 min. Cells were resuspended in label-free chase mix (SD medium,
3.3 mM ammonium sulfate, 0.013% (w/v) L-methionine, 0.01% (w/
v) L-cysteine) and incubated at 30°C. At indicated time points,
samples were collected and degradation was stopped by the addition
of 10 mM sodium azide. Cell lysates were prepared by the addition
of glass beads and vigorous shaking. The protein of interest was
immunoprecipitated with specific antibodies (see Appendix
Table S4). Samples containing PrA*-3xHA or CPY*_K0-HA were
treated with endoglycosidase F. Radioactive signals were analyzed
by autoradiography using a Typhoon FLA9500 (GE Healthcare) and
ImageQuant TL 7.01 software (GE Healthcare). Experiments were
performed at least in triplicates.
During monitoring of Hrd1 model substrate degradation by CHX
decay, we experienced technical problems (signal detection/data
quality needed for quantification). Hence, we switched to pulse-
chase experiments for these substrates. Since sample preparation in
pulse-chase assays is inherently more error-prone (immunoprecipi-
tation of substrate out of every sample), we tried to reduce the use
of this assay by analyzing Doa10 model substrate degradation via
CHX analysis.
NMR spectroscopy
NMR spectra were recorded on a 500 MHz Bruker Avance II
(University of Washington) at 22°C in 25 mM sodium phosphate pH
7.0, 150 mM NaCl, 10% D2O. 1H/15N-HSQC-TROSY experiments
were collected on 200 lM labeled protein, if not indicated other-
wise. Datasets were processed using NMRPipe/NMRDraw (Delaglio
et al, 1995) and visualized with NMRView (Johnson & Blevins,
1994). Chemical shift perturbations observed by 2D HSQC- TROSY
NMR were quantified in parts per million with the equation Dd
(1H/15N) = {[d(1H)  d(1H)0]2 + 0.04[d(15N)  d(15N)0]2}1/2.
Nitrogen relaxation time analyses were performed with delays of
10, 40, 80, 120, 160, 320, 640, and 1,000 ms for T1 and 8.48, 33.92,
42.4, 25.44, 59.36, 16.96, 50.8, and 67.84 ms for T2. Rates and their
respective errors for each analyzed residue were quantified using
the built-in “rate analysis” function of NMRView. Average T1/T2
ratios for the (15N)Ub(G76C) constructs shown in Fig 5C are
presented as the respective means  standard deviation for all
analyzed residues.
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